Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-03-01 @ 5:54 PM
Study NCT ID:
NCT03897205
Status:
COMPLETED
Last Update Posted:
2024-02-28
First Post:
2019-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients
Sponsor:
Hansa Biopharma AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-27
First Submit QC Date:
None
Study First Post Date:
2019-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-10-09
Results First Submit QC Date:
None
Results First Post Date:
2024-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-31
Last Update Post Date:
2024-02-28
Last Update Post Date Type:
ACTUAL